Tianyu Han
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology
- Immunology
- Epidemiology
- Topics
- Cancer, Hypoxia, and Metabolism (13 papers)Ubiquitin and proteasome pathways (9 papers)RNA modifications and cancer (9 papers)
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Tianyu Han
44 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 913
- Cancer Research 485
- Oncology 197
- Immunology 190
- Epidemiology 163
Countries citing papers authored by Tianyu Han
This map shows the geographic impact of Tianyu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianyu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianyu Han more than expected).
Fields of papers citing papers by Tianyu Han
This network shows the impact of papers produced by Tianyu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianyu Han. The network helps show where Tianyu Han may publish in the future.
Co-authorship network of co-authors of Tianyu Han
This figure shows the co-authorship network connecting the top 25 collaborators of Tianyu Han. A scholar is included among the top collaborators of Tianyu Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianyu Han. Tianyu Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 10 | |
| 7 | 4 | |
| 8 | 9 | |
| 9 | 11 | |
| 10 | 2 | |
| 11 | 49 | |
| 12 | 11 | |
| 13 | 10 | |
| 14 | 22 | |
| 15 | 13 | |
| 16 | 156 | |
| 17 | 39 | |
| 18 | 3 | |
| 19 | GRHL2 suppresses tumor metastasis via regulation of transcriptional activity of RhoG in non-small cell lung cancer. | 25 |
| 20 | 9 |
About Tianyu Han
Tianyu Han is a scholar working on Cancer Research, Molecular Biology and Biochemistry, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (13 papers), Ubiquitin and proteasome pathways (9 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Cancer Research (485 citations), Molecular Biology (913 citations) and Immunology (190 citations). Tianyu Han has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Jianbin Wang, Mingxi Gan, Weihua Zhan, Song Zhang, Yanan Wang, Caifeng Xie, Bentong Yu, Meng Guo, Xiaoyu Wang and Wenlong Wu. Their work appears in journals such as PLoS ONE, Bioresource Technology and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.